Keywords: GlaxoSmithKline, BARDA, Antibiotics, GSK2251052, Tuberculosis, Malaria, Anacor, R&D

GlaxoSmithKline partners with BARDA to develop new class of antibiotic; amends deal with Anacor

Article | 08 September 2011

Print This

The US Department of Health and Human Services’ Biomedical Advanced Research and Development Authority (BARDA) has awarded a contract ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in